Diabetes Clinical Trials in New York

Showing 41-60 of 679 trials

A Randomized Trial Evaluating Control-IQ+ Technology in Adults With Type 2 Diabetes

NCT05785832

A randomized controlled trial (RCT) to assess the safety and efficacy of use of Control-IQ+ technology in adults with type 2 diabetes using basal-bolus insulin therapy.

Type 2 Diabetes Treated With Insulin

Tandem Diabetes Care, Inc.319 participantsStarted Jun 2023

Newport Beach, California, United States • Atlanta, Georgia, United States • Idaho Falls, Idaho, United States +18 more locations

Active Not RecruitingPhase 2< 1 mile

Rituximab-pvvr and Abatacept vs Rituximab-pvvr Alone in New Onset Type 1 Diabetes

NCT03929601

The study is a two-arm, multicenter, double-blinded clinical trial testing sequential therapy with rituximab-pvvr followed by abatacept versus rituximab-pvvr alone in new onset T1D. The primary objective is to test whether the C-peptide response to a 2-hour mixed meal tolerance test, will be improved in participants with new onset T1D who are treated with Abatacept after Rituximab-pvvr compared to those treated with Rituximab-pvvr and placebo 24 months after enrollment.

Type 1 Diabetes Mellitus

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)74 participantsStarted Oct 2023

Orange, California, United States • Palo Alto, California, United States • San Francisco, California, United States +16 more locations

A Randomized Trial Evaluating Control-IQ+ Technology in Adults With Type 2 Diabetes

Rituximab-pvvr and Abatacept vs Rituximab-pvvr Alone in New Onset Type 1 Diabetes

Diabetes Trials in Other Cities

Siplizumab in T1DM

A Comparative Effectiveness Study of Major Glycemia-lowering Medications for Treatment of Type 2 Diabetes

Texts for Diabetes Control Among Homeless Persons

Proact: A Study of REACT in Subjects With Type 2 Diabetes Mellitus and Chronic Kidney Disease

DECIDE: A Comparative Effectiveness Trial of Metformin Versus Insulin for the Treatment of Gestational Diabetes

Cholesterol Lowering and Residual Risk in Diabetes, Type 1

CGM for the Early Detection and Management of Hyperglycemia in Pregnancy

Cleaner Air for Lower Cardiometabolic Risk

BRInging the Diabetes Prevention Program to GEriatric Populations

A Study of CT-388 in Participants Who Are Overweight or Obese With Type 2 Diabetes Mellitus

T1DTechCHW: Enhancing the Community Health Worker Model to Promote Diabetes Technology Use in Young Adults From Underrepresented Minority Groups

A Research Study to See How Well CagriSema Compared to Semaglutide, Cagrilintide and Placebo Lowers Blood Sugar and Body Weight in People With Type 2 Diabetes Treated With Metformin With or Without an SGLT2 Inhibitor

Teplizumab in Pediatric Stage 2 Type 1 Diabetes

Omnipod® SmartAdjust 2.0 System Compared to the Omnipod® 5 System in Individuals With Type 1 or Type 2 Diabetes

Efficacy and Safety of Petrelintide in Participants With Overweight or Obesity and Type 2 Diabetes (ZUPREME 2)

A Research Study Comparing How Well Different Doses of the Medicine NNC0487-0111 Lower Blood Sugar in People With Type 2 Diabetes

Study Comparing Acceptance and Commitment Therapy to Supportive Diabetes Counseling and a Waitlist Control for Eating Disorders in Type 1 Diabetes

Cardiovascular Kidney and Metabolic Health Assessment and Patient Empowerment

Other Conditions in New York